Status:
COMPLETED
Non-invasive Hemoglobin Monitoring in Cesarean Section
Lead Sponsor:
Seoul National University Bundang Hospital
Conditions:
Placenta Previa
Eligibility:
FEMALE
20-50 years
Phase:
NA
Brief Summary
Non-invasive hemoglobin monitoring will be performed in patients who underwent cesarean section with placenta previa and this will be compared with actual laboratory findings. The investigators will ...
Eligibility Criteria
Inclusion
- Pregnant woman
- Elective Cesarean section
- Placenta previa
Exclusion
- Decline of consent
- Peripheral vascular disease
- Cyanosis due to congenital heart disease
- Refusal of transfusion
- Mental retardation
Key Trial Info
Start Date :
February 5 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2018
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT03409822
Start Date
February 5 2018
End Date
December 30 2018
Last Update
January 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National Univ. Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea, 463-707